AWM
GILD icon

Ariadne Wealth Management’s Gilead Sciences GILD Stock Holding History

Ariadne Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$670K Sell
5,307
-368
-6% -$48.5K 0.3% 87
2026
Q1 		$791K Sell
5,675
-1,004
-15% -$141K 0.36% 67
2025
Q4 		$1.01M Buy
6,679
+523
+8% +$63.6K 0.42% 53
2025
Q3 		$771K Sell
6,156
-289
-4% -$32.8K 0.35% 64
2025
Q2 		$774K Sell
6,445
-264
-4% -$28.1K 0.37% 58
2025
Q1 		$650K Buy
6,709
+49
+0.7% +$5.06K 0.34% 65
2024
Q4 		$636K Buy
6,660
+737
+12% +$66.4K 0.29% 70
2024
Q3 		$580K Buy
+5,923
New +$452K 0.32% 58

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ariadne Wealth Management's GILD Position: Q2 2026 in Review

Ariadne Wealth Management reduced its Gilead Sciences (GILD) stake by 6.5% in Q2 2026, selling an estimated $48.5K and leaving 5,307 shares worth $670K. The position accounts for 0.3% of the portfolio, ranked #87.

Ariadne Wealth Management first reported a position in GILD in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.01M in Q4 2025. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Ariadne Wealth Management held 5,307 shares of Gilead Sciences worth $670K as of Q2 2026.
  • Ariadne Wealth Management sold 368 Gilead Sciences shares in Q2 2026, an estimated $48.5K.
  • Gilead Sciences made up 0.3% of Ariadne Wealth Management's portfolio in Q2 2026, its #87 holding.
  • Ariadne Wealth Management first reported a position in Gilead Sciences in Q3 2024 and has held it in 8 quarters since.
  • Ariadne Wealth Management's Gilead Sciences position peaked at $1.01M in Q4 2025.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Ariadne Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.